BTLA monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BTLA monoclonal antibody, covering 2025-06-19 to 2025-06-19. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of a Recombinant Humanized mAb Specific to B-and T-Lymphocyte Attenuator (BTLA) for Injection in Subjects With Advanced Malignancies [Phase 1]